GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (ASX:CU6) » Definitions » Other Current Receivables

Clarity Pharmaceuticals (ASX:CU6) Other Current Receivables : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Clarity Pharmaceuticals Other Current Receivables?

Clarity Pharmaceuticals's Other Current Receivables for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Clarity Pharmaceuticals's annual Other Current Receivables increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$6.66 Mil) and increased from Jun. 2022 (A$6.66 Mil) to Jun. 2023 (A$10.00 Mil).


Clarity Pharmaceuticals Other Current Receivables Historical Data

The historical data trend for Clarity Pharmaceuticals's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Other Current Receivables Chart

Clarity Pharmaceuticals Annual Data
Trend Jun22 Jun23
Other Current Receivables
6.66 10.00

Clarity Pharmaceuticals Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Receivables Get a 7-Day Free Trial - 6.66 - 10.00 -

Clarity Pharmaceuticals Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Clarity Pharmaceuticals Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Clarity Pharmaceuticals's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Clarity Pharmaceuticals (ASX:CU6) Business Description

Traded in Other Exchanges
Address
4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.

Clarity Pharmaceuticals (ASX:CU6) Headlines

No Headlines